share_log

Chardan Capital:维持Dyne Therapeutics(DYN.US)评级,由买入调整至买入评级, 目标价由31.00美元调整至31.00美元。

Zhitong Finance ·  May 6 08:15

Chardan Capital:维持Dyne Therapeutics(DYN.US)评级,由买入调整至买入评级, 目标价由31.00美元调整至31.00美元。

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment